Following a turbulent funding environment, biotechs are seeking to generate more data earlier to reassure investors.

This is the second of three feature articles Ars is publishing to explore the financial, technical, and competitive ...

The companies that fail at AI are failing because they treat AI as a product to install rather than a capability to develop.

But questions are crucial in every organisation. They sharpen thinking and extract information when things go wrong. They are ...